Current treatment in COVID-19 disease: a rapid review.
Ontology highlight
ABSTRACT: The world has faced the most challenging pandemic of the modern era, that of severe acute respiratory syndrome coronavirus 2 infection, causing coronavirus disease and affecting over 35 million people globally. The wide range of clinical manifestations associated with this viral disease is thought to be related to the overexpression of inflammatory markers. Due to a dysregulated host response, the most severe form involves multi-organ failure and thromboembolic complications. Immunomodulatory therapies may help prevent its progression and anticoagulation has been shown to reduce the risk of thrombotic complications. As this is a new entity for the medical world, there are no known therapeutic options nor has the prevention of complications been established. Anti-inflammatory agents, antimi
SUBMITTER: Rodriguez-Guerra M
PROVIDER: S-EPMC7850293 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA